Prognostic effect of sarcopenia in patients undergoing laparoscopic rectal cancer resection.
disease-free survival
follow-up
ileopsoas muscle
laparoscopy
overall survival
rectal cancer
recurrence
sarcopenia
skeletal muscle
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
revised:
26
12
2022
received:
10
11
2022
accepted:
27
12
2022
medline:
15
6
2023
pubmed:
10
2
2023
entrez:
9
2
2023
Statut:
ppublish
Résumé
The importance of body composition, in particular skeletal muscle mass, as risk factor affecting survival of cancer patients has recently gained increasing attention. The relationship between sarcopenia and oncological outcomes has become a topic of research in particular in patients with gastrointestinal cancer. However, there are few studies addressing this issue in colorectal cancer, and even less specifically focused on rectal cancer, in particular in Western countries. The aim of this study was to evaluate the prognostic relevance of preoperative skeletal mass index (SMI) on long-term outcomes in patients undergoing laparoscopic curative resection for rectal cancer. SMI data and clinicopathological characteristics of rectal cancer patients in a 15-year period (June 2005-December 2020) were evaluated; patients with metastatic disease at surgery were excluded; overall and disease-free survival as well as recurrence were evaluated. Hundred and sixty-five patients were included in the study. Sarcopenia was identified in 30 (18%) patients. Multivariate analysis identified sarcopenia (HR = 3.28, CI = 1.33-8.11, P = 0.015), along with age (HR = 1.06, CI = 1.02-1.10, P = 0.002) and stage III (HR = 2.63, CI = 1.13-6.08, P < 0.03) as independent risk factors for overall survival. Long-term results of rectal cancer patients undergoing curative resection are affected by their preoperative skeletal muscle status. Larger studies including comprehensive data on muscle strength along with SMI are awaited to confirm these results on both Eastern and Western rectal cancer patient populations before strategies to reverse muscle depletion can be extensively applied.
Sections du résumé
BACKGROUND
The importance of body composition, in particular skeletal muscle mass, as risk factor affecting survival of cancer patients has recently gained increasing attention. The relationship between sarcopenia and oncological outcomes has become a topic of research in particular in patients with gastrointestinal cancer. However, there are few studies addressing this issue in colorectal cancer, and even less specifically focused on rectal cancer, in particular in Western countries. The aim of this study was to evaluate the prognostic relevance of preoperative skeletal mass index (SMI) on long-term outcomes in patients undergoing laparoscopic curative resection for rectal cancer.
METHODS
SMI data and clinicopathological characteristics of rectal cancer patients in a 15-year period (June 2005-December 2020) were evaluated; patients with metastatic disease at surgery were excluded; overall and disease-free survival as well as recurrence were evaluated.
RESULTS
Hundred and sixty-five patients were included in the study. Sarcopenia was identified in 30 (18%) patients. Multivariate analysis identified sarcopenia (HR = 3.28, CI = 1.33-8.11, P = 0.015), along with age (HR = 1.06, CI = 1.02-1.10, P = 0.002) and stage III (HR = 2.63, CI = 1.13-6.08, P < 0.03) as independent risk factors for overall survival.
CONCLUSION
Long-term results of rectal cancer patients undergoing curative resection are affected by their preoperative skeletal muscle status. Larger studies including comprehensive data on muscle strength along with SMI are awaited to confirm these results on both Eastern and Western rectal cancer patient populations before strategies to reverse muscle depletion can be extensively applied.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1631-1637Informations de copyright
© 2023 Royal Australasian College of Surgeons.
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68: 394-424.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J. Clin. 2022; 72: 7-33.
Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat. Rev. Gastroenterol. Hepatol. 2020; 17: 414-29.
Sun Y, Huang Z, Zhang Y et al. Is early initiation of adjuvant chemotherapy beneficial for locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery? World J. Surg. 2020; 44: 3149-57.
Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 2004; 351: 1731-40.
Zhu Y, Guo X, Zhang Q, Yang Y. Prognostic value of sarcopenia in patients with rectal cancer: a meta-analysis. PLoS One 2022; 17: e0270332.
Han JS, Ryu H, Park IJ et al. Association of Body Composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res. Treat. 2020; 52: 563-72.
Levolger S, van Vledder MG, Alberda WJ et al. Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma. Clin. Nutr 2018; 37: 1728-35.
Takeda Y, Akiyoshi T, Matsueda K et al. Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One 2018; 13: e0195406.
Choi MH, Oh SN, Lee IK, Oh ST, Won DD. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J. Cachexia. Sarcopenia Muscle 2018; 9: 53-9.
Hopkins JJ, Reif RL, Bigam DL, Baracos VE, Eurich DT, Sawyer MB. The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer. Dis. Colon Rectum 2019; 62: 549-60.
Park SE, Hwang IG, Choi CH et al. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Medicine (Baltimore) 2018; 97: e13363.
Chung E, Lee HS, Cho E-S et al. Prognostic significance of sarcopenia and skeletal muscle mass change during preoperative chemoradiotherapy in locally advanced rectal cancer. Clin. Nutr 2020; 39: 820-8.
Portale G, Cavallin F, Valdegamberi A, Frigo F, Fiscon V. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio are not prognostic biomarkers in rectal cancer patients with curative resection. J. Gastrointest. Surg. 2018; 22: 1611-8.
Shen W, Punyanitya M, Wang Z et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J. Appl. Physiol. 2004; 1985: 2333-8.
Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl. Physiol. Nutr. Metab 2008; 33: 997-1006.
Prado CMM, Lieffers JR, McCargar LJ et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008; 9: 629-35.
Al-Homoud S, Purkayastha S, Aziz O et al. Evaluating operative risk in colorectal cancer surgery: ASA and POSSUM-based predictive models. Surg. Oncol. 2004; 13: 83-92.
Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J. Clin. Epidemiol. 1994; 47: 1245-51.
Portale G, Valdegamberi A, Cavallin F, Morabito A, Frigo F, Fiscon V. Laparoscopic curative resection for rectal cancer: a cohort study on long-term outcome. Surg. Laparosc. Endosc. Percutan. Tech. 2018; 28: 318-23.
Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992; 48: 73.
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2021 https:wwwR-Proj.
Sjoberg DD, Whiting K, Curry M, Lavery JA, Larmarange J. Reproducible summary tables with the gtsummary package. R J. 2021; 13: 570.
Therneau, T. A Package for Survival Analysis in R. R package version 3.3-1. 2022. https:CRANR-Proj.
Kassambara, A., Kosinski, M. & Biecek, P. Survminer: Drawing Survival Curves using ‘ggplot2’. R package version 0.4.9. 2021. https:CRANR-Proj.
Latorre Fragua RA, Manuel Vázquez A, Ramiro Pérez C, de la Plaza Llamas R, Ramia Ángel JM. Influence of sarcopenia in major pancreatic surgery. A systematic review of the literature. Gastroenterol. Hepatol. 2020; 43: 142-54.
Zhuang C-L, Huang D-D, Pang W-Y et al. Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine (Baltimore) 2016; 95: e3164.
Motoori M, Fujitani K, Sugimura K et al. Skeletal muscle loss during neoadjuvant chemotherapy is an independent risk factor for postoperative infectious complications in patients with advanced esophageal cancer. Oncology 2018; 95: 281-7.
Reisinger KW, Derikx JPM, van Vugt JLA et al. Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer. Clin. Nutr. 2016; 35: 924-7.
Miyamoto Y, Hanna DL, Zhang W, Baba H, Lenz H-J. Molecular pathways: cachexia signaling-a targeted approach to cancer treatment. Clin. Cancer Res. 2016; 22: 3999-4004.
Cruz-Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16-31.
Huang D-D, Wang S-L, Zhuang C-L et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis. 2015; 17: O256-64.
Tankel J, Yellinek S, Vainberg E et al. Sarcopenia defined by muscle quality rather than quantity predicts complications following laparoscopic right hemicolectomy. Int. J. Color. Dis. 2020; 35: 85-94.
Sergi G, Trevisan C, Veronese N, Lucato P, Manzato E. Imaging of sarcopenia. Eur. J. Radiol. 2016; 85: 1519-24.
Lee K, Shin Y, Huh J et al. Recent issues on body composition imaging for sarcopenia evaluation. Korean J. Radiol. 2019; 20: 205-17.